Showing results (151-160 of 341) with videos related to

Sort By:
Pageof 35
European Heart Journal|March 23, 2017
Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivorsLaura Pasea, Sheng-Chia Chung, Mar Pujades-Rodriguez, et al.
European Heart Journal|July 30, 2025
Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fractionMasatake Kobayashi, Antoni Bayes-Genis, Kevin Duarte, et al.
European Journal of Heart Failure|June 17, 2022
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-ReducedFaiez Zannad, João Pedro Ferreira, John Gregson, et al.
The Canadian Journal of Cardiology|July 13, 2024
Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic ApproachesJohn W Eikelboom, Qilong Yi, William F McIntyre, et al.
JAMA Cardiology|October 2, 2024
Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy: The CHAGASICS Randomized Clinical TrialMartino Martinelli-Filho, José A Marin-Neto, Mauricio Ibrahim Scanavacca, et al.
Circulation|October 23, 2020
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-ReducedFaiez Zannad, João Pedro Ferreira, Stuart J Pocock, et al.
International Journal of Cardiology|November 13, 2020
Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia studyJuan Zhou, Chee Tang Chin, Xin Huang, et al.
European Journal of Heart Failure|February 24, 2007
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programmeNathaniel M Hawkins, Duolao Wang, John J V McMurray, et al.
The American Journal of Cardiology|September 28, 2011
Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials)Peter Damman, Lene Holmvang, Jan G P Tijssen, et al.
American Heart Journal|October 8, 2013
Learning from recent trials and shaping the future of acute heart failure trialsRobert J Mentz, Gary Michael Felker, Tariq Ahmad, et al.
Pageof 35